Login / Signup

Efficacy and safety of Jian-Pi Huo-Xue granule for non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled trial.

Yuanlong SunGaofeng ChenSi ChenYanjie WangYiyang HuYu Zhao
Published in: Trials (2022)
Chinese Clinical Trial Registry ChiCTR2100046132 . Registered on 4 May 2021.
Keyphrases
  • double blind
  • clinical trial
  • placebo controlled
  • phase ii
  • phase iii
  • study protocol
  • liver fibrosis
  • open label